
Centre for Advanced Cell Therapy (ACT), Oslo University Hospital · Oslo
A 2-year position as a researcher is available at the Centre for Advanced Cell Therapy (ACT), Oslo University Hospital, under the supervision of the ACT Directo...
A 2-year position as a researcher is available at the Centre for Advanced Cell Therapy (ACT), Oslo University Hospital, under the supervision of the ACT Director Anna Pasetto. The position will be located at the pre-GMP facility at the Norwegian Radium Hospital, Oslo.
The ACT Centre is a core facility and translational research environment dedicated to accelerating the development and clinical implementation of advanced cell therapies. We are looking for a highly motivated candidate with a strong interest in translational cell therapy, process development, and quality control methods for advanced therapy medicinal products.
About the project
The successful candidate will work on the optimization and development of manufacturing and quality control processes for cell therapy products. The project will involve the development, testing, and implementation of new protocols for cell therapy manufacturing, analytical characterization, and potency/functionality assessment. A key focus will be the introduction and evaluation of automated solutions for manufacturing and QC workflows, in close collaboration with national and international academic and industry partners. The work will be performed in the pre-GMP facility at the Norwegian Radium Hospital and will support the translation of innovative cell therapy approaches towards clinical application.
Oslo University Hospital is a workplace with great diversity. We believe this is crucial to solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions, and encourage all qualified candidates, regardless of background, to apply.
Main tasks
The applicant must hold a PhD in immunology, cell biology, biotechnology, molecular biology, biomedical sciences, or a related discipline.
We are looking for a candidate who is scientifically curious, technically skilled, solution-oriented, and motivated to contribute to the clinical translation of advanced cell therapies. The candidate should enjoy working in a collaborative environment and be comfortable interacting with academic researchers, clinical teams, technical staff, and industry partners.
We offer
The position is based at the Norwegian Radium Hospital, Oslo University Hospital.
KontaktinformasjonAnna Pasetto, Unit leader, annpas@ous-hf.no; anna.pasetto@medisin.uio.no
ArbeidsstedUllernchausseen 70
0310 Oslo
Nøkkelinformasjon:Arbeidsgiver: Oslo universitetssykehus HF
Referansenr.: 5150532921
Stillingsprosent: 100%
Contract
Søknadsfrist: 24.07.2026
We announce 80%, one-year extendable researcher position in the CRISPR gene therapy group led by Emma Haapaniemi to be based at NCMBM, University of Oslo & Oslo University Hospital. We welcome applications both from recent PhD graduates and more experienced scientists. The successful candidate will join a highly integrated and motivated team with diverse skills and expertise across molecular biology and immunology. The work tasks will concentrate on optimizing and scaling up protocols for efficient mutation correction in human T cells and hematopoietic stem cells utilizing CRISPR-Cas9 gene editing technologies. Examples of work tasks include optimization of patient-derived T cell and stem cell ex vivo editing & culturing conditions; establishing functional assays; design and optimizing high-throughput biology experiments in robotics platforms; setting up custom Next Generation Sequencing libraries and technologies; scale up protocols to pre-GMP and GMP scale About the laboratory The aim of the Haapaniemi group (www.haapaniemilab.org) is to build a gene editing platform that can be used to correct patient-specific mutations in ex vivo cell therapies for genetic immune and other rare childhood diseases. We use high-throughput biology techniques to optimize, develop and understand the CRISPR-Cas9 system that forms the base of the platform, and develop and implement methods to evaluate its safety in a clinical setting. We will use gene editing technologies for the benefit of the patients in Nordic hospitals. Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) was established in 2008 and is the Norwegian node in the Nordic EMBL Partnership for Molecular Medicine. NCMM is a joint venture between the University of Oslo, Health Region South-East and the Research Council of Norway, and has altogether 11 research groups. The overall objective of NCMM is to conduct cutting edge research in molecular medicine and biotechnology as well as facilitate translation of discoveries in basic medical research into clinical practice. Oslo University Hospital is a workplace with great diversity. We believe this is crucial for solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions, and we encourage all qualified candidates, regardless of background, to apply! Arbeidsoppgaver • Design and conduct custom CRISPR experiments and screens in high-throughput robotics platforms • Set up custom Next Generation Sequencing libraries and technologies • Set up functional assays for immune cells • Supervise students and technicians in designing and conducting molecular biology experiments Kvalifikasjoner • PhD in molecular biology, biology or immunology with researcher/ postdoctoral researcher experience of min 4 years • Documented experience with the following techniques: previous experience in CRISPR-Cas9 gene editing in healthy and patient-derived T cells, Next Generation Sequencing library preparation, immune cell culture, flow cytometry and droplet digital PCR • At least 3 published first-author papers and 3 as a last/senior author • Experience in supervising interns, masters and PhD students (both co- and main supervisor) • Experience in genetic analyses • Fluent oral and written English communication skills The application must include: • Cover letter (statement of motivation, summarizing scientific work and research interest) • CV (summarizing education, positions, pedagogical or administrative experience and other qualifying activity) • Copies of educational certificates (academic transcripts only) • List of publications • List of 3 reference people (name, relation to candidate, e-mail and phone number) Personlige egenskaper • Organized and independent • Ability to communicate and work in shared multidisciplinary projects • Willingness to supervise students • Enthusiastic and hard-working scientist Vi tilbyr • Salary depending on qualifications • An exciting, translational project where your strong basic science background can directly benefit our sickest patients • Attractive welfare benefits and a generous pension agreement, in addition to Oslo’s family-friendly environment with its rich opportunities for culture and outdoor activities Kontaktinformasjon Runar Almaas, Avdelingsleder, +4741321932 Arbeidssted Sognsvannsveien 20 0372 Oslo Nøkkelinformasjon: Arbeidsgiver: Oslo universitetssykehus HF Referansenr.: 5153443482 Stillingsprosent: 80% Engasjement Startdato: 01.08.2026 Sluttdato: 31.07.2027 Søknadsfrist: 24.07.2026
Om stillingen Ved Fakultet for helsevitenskap, Institutt for naturvitenskapelige helsefag, er det en ledig stilling som ph.d.-stipendiat for å undersøke anvendelse av glykomikk til å diagnostisere sepsis. Stillingen har en varighet på tre år, med ønsket oppstart senest 01.04.27. Prosjektet er et tverrfaglig forskningssamarbeid mellom glykomikkgruppen ledet av professor Niclas Karlsson og SEPSOMICS-gruppen ved Oslo Universitetssykehus, Ullevål. Målet er å identifisere undergrupper av sepsispasienter basert på deres glykoproteiner, for å forbedre diagnostikk og muliggjøre persontilpasset behandling. Prosjektet vil benytte topp moderne MS- og ikke-MS-baserte glykomikkmetoder sammenstilt med klinisk pasientinformasjon. Forskningsområde Dette ph.d.-prosjektet vil utforske sepsisens glykobiologi, med mål om å identifisere glykanbaserte biomarkører for pasientstratifisering og bedre behandling. Sepsis er en alvorlig tilstand forårsaket av en dysregulert immunrespons på infeksjon, med en dødelighet på mellom 15 % og 30 %. Det er et akutt behov for å forstå de molekylære mekanismene bak denne dysreguleringen for å muliggjøre persontilpasset behandling. Vi vil studere endret plasmaglykosylering hos sepsispasienter, samt glykosyleringsmønstre i ekstracellulære vesikler (EV) som frigjøres under sepsis og kan gi ny innsikt i immundysreguleringen som kjennetegner pasientene. Målet er å identifisere en glykofenotype hos pasienter med sepsis som muliggjøre målrettet behandling og reduserer unødvendig bruk av bredspektrede antibiotika. Prosjektet støttes av et verdensledende team innen glykomikk og EV-biokjemi, og vil utnytte en høykvalitets biobank med norske sepsispasienter og relevante kontrollgrupper. Som stipendiat ved OsloMet har du mulighet til å søke om stipend for lengre forskningsopphold i utlandet. Kvalifikasjonskrav og vilkår • Mastergrad (120 studiepoeng/ECTS) innen naturvitenskap (farmasi, analytisk kjemi, biokjemi, biomedisin eller tilsvarende) • Dokumentert erfaring med relevant biokjemisk laboratoriearbeid • Gode engelskkunnskaper, både skriftlig og muntlig • Opptak til doktorgradsprogrammet i helsevitenskap er en forutsetning for å tiltre i stillingen. For å få opptak på ph.d. -programmene på Fakultetet for helsevitenskap må søkere ha B eller bedre på masteroppgaven/hovedfagsoppgaven (eller karakter ansett som likeverdig) og gjennomsnittskarakter tilsvarende B eller bedre på mastergraden. I særskilte tilfeller kan søkere med karakteren C vurderes. I slike tilfeller vil særlig relevant erfaring knyttet til forskningsprosjekt og/eller vitenskapelig publisering bli vektlagt. Se informasjon om kriterier på nettsiden for opptak • Endelig plan for forskerutdanning skal være godkjent og avtalefestet senest 3 måneder etter tiltredelse Generelle kriterier for ansettelse som stipendiat fremgår av forskriften (Forskrift til universitets- og h.øyskoleloven- Lovdata) Det vil være en fordel om du har • dokumentert erfaring med praktisk biologisk massespektrometri, glykomikk og/eller glykobiologi • erfaring fra arbeid med omics, big data og statistikk ved bruk av R eller liknende • god forståelse for biologiske sykdomsprosesser • erfaring med å bruke KI/maskinlæring for å forutsi helseutfall • ferdigheter (både skriftlig og muntlig) i et skandinavisk språk Vi tilbyr • en spennende utdanningsstilling ved Norges tredje største universitet • tilgang til faglig videreutvikling i et kreativt fag- og forskningsmiljø • fleksibel arbeidstid og arbeidsplass midt i Oslo sentrum • Internasjonal forskningsmobilitet, siden den valgte kandidaten forventes å være involvert i arbeidsutveksling med europeiske forskningspartnere og presentere arbeid på nasjonale og internasjonale konferanser og workshops. • Du vil ta del i et spennende og viktig forskningsprosjekt. Du vil jobbe med klinikere, biokjemiker, biostatistikere og glykobiologer for å utforske basale biologiske mekanismer i en livstruende akutt sykdomstilstand som ramme mange pasienter. • Pensjonsbetingelser i Statens pensjonskasse (SPK) • Gode velferdsordninger Stillingen lønnes iht. Hovedtariffavtalene i staten og OsloMets lønnspolitikk i stillingskode 1017 som stipendiat, ltr. 54 kr. 532 200,- pr. år. Video: https://www.youtube.com/watch?v=SHi5avzdHIkSøknadsprosess Vil du søke på stillingen må du søke via vårt rekrutteringssystem. Innen søknadsfristen må du laste opp følgende dokumenter: • søknadsbrev • CV, attester og alle sider av vitnemål. Utenlandsk utdanning bør være godkjent på forhånd, og godkjenningsbrev vedlegges. Informasjon finnes via lenken: Godkjenning av utenlandsk utdanning – jobb i Norge | HK-dir • masteroppgave/hovedfasoppgave • last opp eventuelle vitenskapelige arbeider eller lenke til full artikkel • liste over eventuelle publikasjoner og presentasjoner på internasjonale semnarer/konferanse • gjerne kontaktinformasjon til to referanser Vi behandler kun søknader sendt via vårt elektroniske rekrutteringssystem og alle dokumenter må lastes opp for at din søknad skal behandles. Dokumentene må være på et skandinavisk språk eller engelsk. Oversettelser må være autorisert og du må påregne å fremvise originaler ved et eventuelt intervju. OsloMet gjennomfører kontroll av dokumenter, slik at du som kandidat skal få en reell evaluering og rettferdig konkurranse. Ufullstendige søknader vil ikke bli tatt til vurdering. For aktuelle stillinger gjennomfører OsloMet bakgrunnssjekk av søkere i samarbeid med en ekstern leverandør, for å verifisere opplysninger som fremgår av tilgjengelige dokumenter. Bakgrunnssjekk skjer alltid med kandidatens samtykke, og ansettelse i disse stillingene forutsetter godkjent bakgrunnssjekk. Aktuelle søkere vil motta nærmere informasjon om dette. For nærmere informasjon om stillingen, kontakt: • Professor Niclas Karlsson , niclaska@oslomet.no • For administrative spørsmål HR rådgiver Kate Olsen, kateol@oslomet.no Søknadsfrist:13.august 2026 Informasjon til deg som søker Inkludering og mangfold styrker vår evne til å løse OsloMets samfunnsoppdrag. Derfor ønsker vi medarbeidere med ulike kompetanser, livserfaringer og perspektiver velkommen. Vi arbeider kontinuerlig for å være en inkluderende arbeidsplass, og gjennom dialog tilrettelegger vi for medarbeidere som har behov for det. OsloMet er EU sertifisert HR Center of Excellence for Charter & Code for forskere som støtter karrieremuligheter, mobilitet og arbeidstaker rettigheter for forskere. OsloMet har sluttet seg til prinsippene og forpliktet institusjonen til å følge anbefalingene i DORA-erklæringen (sfdora.org) (The San Francisco Declaration on Research Assessment). Ansettelsen blir gjennomført etter prinsippene i statsansatteloven og lovverk som regulerer eksport av kunnskap, teknologi og tjenester. Søkere som er i konflikt med dette regelverket vil ikke anses kvalifisert for stillingen. Besøk OsloMet på LinkedIn, Facebook, Instagram
Description Postdo ctoral Researcher – Development and F unctional V alidation of A dvanced M agnetic N anocomposites for B iomedical A pplications Job Referen ce: Ref.23.26.422 Employer: International Iberian Nanotechnology Laboratory (INL) Location: Braga, Portugal Group/Unit: Bañobre Research Group Number of Vacancies: 1 Employment Type: Full time Contract Duration: 12 months Salary Range: 28K-3 1 K Open Date for Applications: July 1 5 th , 2026 Closing Date for Applications : August 4 th , 2026 , 23h00m (Lisbon Time) Key words: #materialschemistry #nanomaterialssynthesis #nanocomposites #nanomaterials #characterisationtechniques #mammaliancellculture Overview The Bañobre Research Group focus is nanomedicine for the development of diagnostic and therapeutic approaches towards an early and unequivocal diagnosis and treatment of cancer, inflammatory and neurological diseases . To this aim the group covers from fundamental research on the identification and validation of diseases’ biomarkers and cellular interactions, to a more applied cross-disciplinary research focused on the development of technologies and nanostructures (inorganic, organic, hybrid) for precision disease diagnosis, therapy and theranostics . We are currently looking for a Postdoctoral Researcher to join our team under the TEN4CARE project. Job Duties T he job duties will be the following : Synthesis e magnetic nanoparticles and nanocomposites . Surface functionali s ation of nanomaterials . Comprehensive physicochemical characteri s ation of (nano)materials . Cell culture techniques and biological assays . Participate in consortium meetings and collaborative activities . Prepare and present regular progress reports . Mandatory Qualifications Education PhD in Nanotechnology, Nanomedicine, Chemistry, Biochemistry or equivalent field. Experience and Technical Skills Experience in nanotechnology and/or nanomedicine research . Hands-on experience in the synthesis and physicochemical characteri s ation of nanomaterials, including magnetic nanoparticles and nanocomposites . Experience in the functionali s ation of nanostructures with bioactive agents (e.g., small molecules, peptides, proteins, nucleic acids) . Proficiency in advanced characteri s ation techniques, such as TEM, SEM, ICP, TGA, HPLC, VSM, SQUID, MRI, and magnetic hyperthermia . Experience in mammalian cell culture and in vitro biological assays for the evaluation of nanomaterial–cell interactions . Other Valued Skills Advanced cell culture skills: co-culture, spheroids, organoids and microfluidic-integration . Drug delivery systems . Theoretical and practical knowledge on NMR, MRI and Magnetic Hyperthermia . Knowledge on organic and polymeric chemistry . Experience in nanomedical applications, including regenerative medicine . Previous participation in collaborative national, international and/or industrial research projects. Personal Skills “Hands-on” approach together with a high commitment in respecting working deadlines; Problem Solving ability ; Customer orient ation ; Ability to work independently and as team player; Good communication skills. Our Benefits Competitive salary ; Tax benefits and other Diplomatic privileges; Private health i nsurance; F amily allowance s (according to family situation); Free nursery service at INL premises (subject to availability); Support for e ducation fees of dependent children; Relocation support; 30 working days o f annual leave. How to Apply The application must be in English and include the following mandatory documents : a) Cover letter b) Curriculum Vitae c) Academic and/or Professional diplomas Online application instructions: The application is made online by clicking the “Apply ” button; The candidate must complete all required sections of the online application form ; The candidate must submit the m andatory documents mentioned above in pdf format by including them in the “A dditional files” sectio n using the “Add portfolio” button. Important note: Incomplete applications including the failure to provide mandatory documents or providing inaccurate information will result in the application not being considered. How the Selection P rocess works A. Applications e ligibility check This stage will be carried out on the basis of the mandatory requirements, education, experience and techn ical skills defined for the job, as well as the validation of the mandatory documents. Only candidates who meet the eligibility criteria will move forward to t he next stage . B. CV Assessment T he Selection Committee will evaluate the eligible applications based on their CV and other submitted documents and the suitability for the position. The best ranked candidates will be shortlisted for the interview stage(s). C. Interview(s) The interview(s) may be done in different formats: video recording , online or onsite. The question based interview will evaluat e the match between the candid ate’s profile and the requirements for the position, including the technical and personal skills. To better support this stage, the candidate may be requested to prepare a short presentation. D. Nomination The selected candidate will be nominated and formally offered the position, including the disclosure of the contractual conditions. Additional Information Application feedback We highly value your interest in becoming part of the INL experience and it is important for us to maintain good c ommunications with all candidate s. No matter the outcome of your application, we will always provide you with feedback . Equal Opportunity and Non-Discrimination Principle INL follows a non-discri mination and equal access principle , wherefore no candidate can be privileged, benefited, impaired or deprived of any rights whatsoever, or be exempt of and duties based on any possible discriminatory issues. The advertisement deadline may be extended at any time without previous notice in order to improve the suitability and effectiveness of the recruitment process. About INL The International Iberian Nanotechnology Laboratory – INL ( http://www.inl.int ), is the first and only Intergovernmental Organisation in the world entirely focused on Nanoscience and Nanotechnology. It was founded under an international legal framework to perform interdisciplinary research, deploy and communicate nanotechnology for the benefit of society. INL aims to be a recognised leading global nanotechnology innovation hub.